Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Medicamen Biotech Limited is a pharmaceutical company that manufactures and markets a variety of pharmaceutical formulations globally. Its product range includes tablets, capsules, liquid syrups, and dry syrups.
Medicamen Biotech major competitors are Albert David, Jenburkt Pharma, Brooks Laboratories, Fredun Pharma, Zim Laboratories, Lyka Labs, Trident Lifeline.
Market Cap of Medicamen Biotech is ₹469 Crs.
While the median market cap of its peers are ₹409 Crs.
Medicamen Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Medicamen Biotech is 5.28 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | Sep | Mar Sep Dec | Sep | Mar Jun Sep | Jun | Jun Sep | ||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
